Page last updated: 2024-10-29

avapro and Ischemia

avapro has been researched along with Ischemia in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meijer, P1
Wouters, CW1
Oyen, WJ1
Boerman, OC1
Scheffer, GJ1
Smits, P1
Rongen, GA1
Recordati, G1
Zorzoli, F1
Pontara, O1
Turolo, L1
Zanchetti, A1

Trials

1 trial available for avapro and Ischemia

ArticleYear
Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:6

    Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Annexin A5; Apoptosis; Biphenyl Compound

2011

Other Studies

1 other study available for avapro and Ischemia

ArticleYear
Factors influencing acute ischaemia-induced renal hypertension in rats.
    Journal of hypertension, 2002, Volume: 20, Issue:12

    Topics: Acute Disease; Animals; Antihypertensive Agents; Biphenyl Compounds; Diuresis; Hematocrit; Hypertens

2002
chemdatabank.com